Home /NEWS / COVID-19 Planning & Response from Eurofins BioPharma Testing (BPT) Group ANZ

COVID-19 Planning & Response from Eurofins BioPharma Testing (BPT) Group ANZ

March 2020

Updated 25 March 2020, at 8:00am

The current COVID-19 pandemic has presented a number of challenges to our industry and the continuing supply of pharmaceutical products to the market.

Despite these challenges, we wish to reassure you of the ongoing commitment by the Eurofins BioPharma Testing Group ANZ (ams SYD, Chemical Analysis MEL and BPT ANZ Auckland) to supporting your business needs and the delivery of quality testing services.

Eurofins BPT Group sites are planning to continue as an essential service, as well as continuing to comply with any and all government directives and requirements.

We will continue to update you with information in regard to any changes as the current situation continues to move very quickly, as well as updating this section of our websites.

Those ams SYD and BPT ANZ Clients working from home may find LabAccess.com helpful. This secure portal provides real-time access to their testing data 24 hours a day / 7 days a week. Chemical Analysis MEL will also offer Lab Access to its Clients later this year.

Please notify us via email (nzbiopharma@eurofins.com or amslabs@eurofins.com) after creating a LabAccess account online and we will activate your account.

If you require any assistance with product testing or to address any urgent testing requirements, please contact your local BPT Group ANZ site to discuss how we may be able to help.

Eurofins ams Laboratories Sydney: +61 2 9704 2300 amslabs@eurofins.com
Eurofins Chemical Analysis Melbourne: +61 3 9737 4300 info@chemicalanalysis.com.au
Eurofins BPT ANZ Auckland: +64 9 579 2669 nzbiopharma@eurofins.com